pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Marketed
insulin isophane
Humulin N (insulin isophane [INN])
Type 1 Diabetes (Juvenile Diabetes)
Lilly USA LLC
Phase 1
insulin lispro biosimilar
Admelog Solostar
Diabetes
Tonghua Dongbao Pharmaceutical Co Ltd
Marketed
interferon alfa-2b
Intron A (interferon alfa-2b)
Genital Warts (Condylomata Acuminata)
Schering-Plough Corp (Inactive)
← prev
page 187 of 231
next →
Pain
89
Neurology
1
Phase 2
interferon alpha
Warts
$AIMD
Ainos, Inc.
Marketed
interferon beta-1a
Rebif (interferon beta-1a)
Relapsing Remitting Multiple Sclerosis (RRMS)
EMD Serono Inc
Marketed
interferon beta-1b
Betaseron (interferon beta-1b)
Relapsing Remitting Multiple Sclerosis (RRMS)
Bayer HealthCare Pharmaceuticals Inc
Marketed
interferon gamma-1b
Actimmune (interferon gamma-1b)
Osteopetrosis
Horizon Therapeutics USA Inc
Phase 2
intismeran autogene
intismeran autogene
Metastatic Melanoma
$MRNA
Moderna, Inc.
Phase 2
invikafusp alfa
invikafusp alfa [INN]
Triple-Negative Breast Cancer (TNBC)
Marengo Therapeutics Inc
Phase 2
iobenguane I 131
iobenguane I 131
Neuroblastoma
Jubilant DraxImage Inc
Phase 3
iodine i 131 apamistamab
Iomab-B (iodine i 131 apamistamab)
Refractory Acute Myeloid Leukemia
$ATNM
Actinium Pharmaceuticals, Inc.
Phase 2
iodofalan I 131
iodofalan I 131
Recurrent Glioblastoma Multiforme (GBM)
$TLX
Telix Pharmaceuticals Ltd
Phase 2
iopofosine i-131
iopofosine i-131
Multiple Myeloma (Kahler Disease)
$CLRB
Cellectar Biosciences, Inc.
Phase 3
ipilimumab + nivolumab
Opdivo + Yervoy (ipilimumab + nivolumab)
Gastric Cancer
Bristol-Myers Squibb Co
Marketed
ipratropium bromide
Ipratropium Bromide
Chronic Bronchitis
The Ritedose Corp
Phase 3
ipsoprubart
ipsoprubart [INN]
Hemophagocytic Lymphohistiocytosis
Electra Therapeutics Inc
Marketed
iptacopan hydrochloride
Fabhalta (iptacopan hydrochloride)
Myasthenia Gravis
$NVS
NOVARTIS AG
Phase 2
irinotecan
irinotecan [INN]
Gastric Cancer
Ascelia Pharma AB
Phase 3
iron sucrose + stannic protoporfin
iron sucrose + stannic protoporfin
Acute Renal Failure (ARF) (Acute Kidney Injury)
Renibus Therapeutics Inc
Phase 2
irsenontrine maleate
irsenontrine maleate
Lewy Body Dementia
Eisai Co Ltd
Phase 2
isaralgagene civaparvovec
isaralgagene civaparvovec [INN]
Fabry Disease
$SGMO
SANGAMO THERAPEUTICS, INC
pre_registration
isatuximab
Sarclisa (isatuximab-irfc)
Refractory Multiple Myeloma
$SNY
Sanofi
Marketed
isocarboxazid
Marplan (isocarboxazid [INN])
Depression
Hoffmann-La Roche Inc
Phase 3
isoflurane
Isoflurane
Sedation
Sedana Medical AB
Phase 2
isomiosamine
isomiosamine [INN]
Sarcopenia
$QCLS
Q/C TECHNOLOGIES, INC.
Marketed
isoniazid
Isoniazid (isoniazid [INN])
Tuberculosis
CMP Pharma Inc
Marketed
isosorbide dinitrate
Isosorbide Dinitrate
Angina (Angina Pectoris)
Par Pharmaceutical Inc
Marketed
isosorbide mononitrate
Isosorbide Mononitrate Lannett (isosorbide mononitrate)
Angina (Angina Pectoris)
Lannett Co Inc
Marketed
isradipine
Isradipine
Hypertension
Elite Laboratories Inc
Phase 2
istaroxime
istaroxime [INN]
Acute Heart Failure
Windtree Therapeutics Inc
